ADHD
Search documents
成龙自曝有ADHD,这到底是个什么病?专家解读丨健康科代表
Xin Lang Cai Jing· 2026-02-01 15:13
主创:何嘉琦 魏冯 转自:四川在线 1月30日,成龙在发视频分享自己的生活,他聊到自己被ADHD困扰的情况,引发关注。什么是ADHD?如何诊断和科学干预?本期"健康科代 表"特别邀请到四川省人民医院温江院区/四川省精神医学中心综合心身/儿少科主任黄雨兰,为我们答疑。 ...
每日快播:以为是晚熟,宁波二年级男孩却确诊为ADHD……每16个娃就有1个中招!出现这些问题务必引起重视
Huan Qiu Wang· 2026-01-20 08:10
本文转自【宁波晚报】; "程主任,老师说我儿子最近还是有很大进步的,我看他在家写作业的速度也比之前快了。"近日,小明 (化名)跟着妈妈来到宁波大学附属康宁医院儿少心理科程芳主任医师的门诊复诊,说到孩子近期的变 化,妈妈的言谈中透着欣慰。 (资料图片仅供参考) 以为是晚熟,结果确诊ADHD 小明今年读二年级,是班上出名的调皮蛋。老师讲课时,他的一只手藏在课桌肚里,把铅笔转得飞快, 另一个手的指尖则夹着半块橡皮,抠成碎屑,落得满桌都是。邻座的女同学想认真听讲,他却用笔轻戳 对方后背,换来对方一个不耐烦的眼神。被老师点到名字回答问题时,小明手忙脚乱地想翻课本,却发 现根本找不到课本。 这是他上课的常态,一年级时就这样,还因此被其他家长投诉,换了好几任同桌。老师也多次私下跟小 明妈妈沟通,并要求小明上课不准再把手放到课桌肚里,要老老实实放在桌面上。然而一段时间之后, 妈妈发现小明的指甲被啃得乱七八糟,尤其是大拇指的指甲,已经短得深深嵌进肉里…… 家里人本来觉得男孩子相对晚熟一些,刚上小学有些不适应是正常的,因此也没想着要带小明看医生。 但眼看着他二年级了情况依然没有多少改观,作业本上一片醒目的红叉叉,在家老老实实做一 ...
被 ADHD 困扰的不止罗永浩,我想分享几个能帮上忙的 AI 工具
3 6 Ke· 2026-01-07 04:13
在迟到了 40 分钟之后,老罗终于在 2025 年的最后一天,站上了科技春晚的舞台。对那些枯等了许久的现场观众,他给到的除了免票,还有一个「理 由」:ADHD。 ADHD 是注意缺陷多动障碍(Attention Deficit Hyperactivity Disorder)的缩写,它最常见的症状是分心、冲动、无法专注,究其核心,都是注意力调节能 力的失灵,且是由于大脑发育带来的。 老实说,当代人,谁不碰上点儿拖延和分心呢——电脑上开着 50 个浏览器标签页,背景音乐还在循环播放洗脑神曲,同时人却划着手机,在小红书上晃 荡了整整 20 分钟——谁还没试过呢? 踩不动油门?注入一点 AI 一颗 ADHD 大脑也会出现上述情况,但背后有明确的病理机制。我们大脑的前额叶皮层负责做规划、踩油门、控刹车,来管理我们的行动。但 ADHD 人 的前额叶活跃度,明显低于平均水平,导致执行功能就像一个延迟极高的无线遥控器:脑子里发出的指令是「现在起床」,但指令传到身体时可能已经卡 顿了一个小时。 这是 ADHD 的典型症状之一:启动困难。也是普通拖延症和 ADHD 的甄别关键:普通拖延症可能是不想做、懒得做,但是 ADHD 是在 ...
分心不是你的错——成人 ADHD 问诊指南
3 6 Ke· 2026-01-04 23:46
本文最早发布于 2021 年。文章发表后,我收到了许多正面反馈,不少朋友都说是因为读到了这篇文章才知道了 ADHD,甚至走进医院,获得 了医生的帮助和诊疗。 而在 2025 年的罗永浩科技创新发布会后,老罗发布了一条微博,表达了自己因为 ADHD 而拖延和患得患失,最终影响了直播效果的感慨。 ADHD 因此再度登上微博热搜,又一次成为公众话题。 因此,我在补充了新信息、新内容后重推本文,希望你可以了解 ADHD,也希望能帮助更多疑似或已经确诊为 ADHD 的朋友们走出困境。 也许你在工作和生活中时常遇到这样的问题:精神不集中,很难长时间只做某项工作,非常容易分神;情绪不稳定,对于他人的行动没有耐心,易怒;严 重拖延,经常踩着死线甚至跨过死线完成项目。如果你在分神、冲动或拖延的时候内心充满了自责与困扰,但就是无法控制自己的注意力和行动力,那你 有可能和我一样,也是 ADHD 患者。 在 2016 年的「罗辑思维读书会」上,罗永浩分享了一本冷门书籍《分心不是我的错》,这是 ADHD 这个概念在国内声量最大的一次曝光和讨论。事实 上,全球大约有 6% 到 8% 的儿童都或轻或重地患有 ADHD,其中一些可以在成长过 ...
罗永浩患上的ADHD,到底是什么?
36氪· 2026-01-04 13:34
以下文章来源于果壳 ,作者见文末 果壳 . 创业者的隐形挑战:罗永浩的ADHD坦白 。 文 | 窗敲雨、透明 编辑 | 李小葵 来源| 果壳(ID:Guokr42) 封面来源 | IC Photo 2025年最后一天,还出了热点新闻。 12月30日的发布会,罗永浩又又又迟到了。上场后他表示"发生了一些事情,向大家道歉。后续会发文解释一下,希望大家理解"。于是今早网友们醒来,看 到了这样一条微博。 科学和技术,是我们和这个世界对话所用的语言。 罗永浩说的问题,都和ADHD有关吗? 先看罗永浩微博中的第1点"发布会没有彩排"和第2点"幻灯片做不完"——这些符合成人ADHD的典型症状。 不同于儿童ADHD突出的多动症状, 成人ADHD最显著的表现通常是注意缺陷。 注意力不集中,如阅读、写作和做事时注意力难以持续,导致患者很难坚 持做完一件事情,尤其是对于注意力维持要求较高的任务或工作(如完成有一定难度的备课、写作、制作幻灯片等),因而经常回避、拖延、草率应付或不 能完成任务。"幻灯片做不完"有可能是由于这样的原因。 同时, 成人ADHD患者存在明显的执行功能障碍 ,主要表现为计划、组织安排工作、学习和家务困难,安排 ...
罗永浩自曝患病服药十几年,如今最大剂量也“不太管用”?
Mei Ri Jing Ji Xin Wen· 2025-12-31 23:18
Group 1: Event Overview - The 2025 Technology Innovation Sharing Conference hosted by Luo Yonghao was held in Shanghai on December 30, but he arrived over 40 minutes late [1] - Luo announced a full refund for ticket prices ranging from 300 to 1000 yuan and apologized, stating he would write a confession letter [3] Group 2: ADHD and Treatment Insights - Luo Yonghao revealed that his tardiness was related to ADHD, a condition he has suffered from for over a decade [3][7] - According to the 2023 edition of the "Chinese Adult ADHD Diagnosis and Treatment Expert Consensus," the prevalence of ADHD among adults in China is approximately 3% [5] - Current treatments for ADHD include medication, psychological therapy, and behavioral training, with medication being the most effective [5][9] Group 3: Medication Landscape - The primary medication for ADHD in China is methylphenidate, marketed as "Zhuanzhu Da," which is the only approved import for this treatment in the past 20 years [5][9] - The long-acting formulation of methylphenidate has shown significant efficacy and is recommended as a first-line treatment for adult ADHD patients [9] - The market for ADHD medications is expanding, with sales in domestic sample hospitals reaching approximately 350 million yuan in 2023, and further growth to about 430 million yuan in the first three quarters of 2024 [11] Group 4: Market Dynamics and Competition - The introduction of the first generic version of methylphenidate by Lifan Pharmaceutical in September 2023 has broken the 20-year monopoly of "Zhuanzhu Da" [11][12] - Other companies, such as China Resources Double Crane and Suzhou First Pharmaceutical, hold production licenses for regular formulations of methylphenidate, but these are less effective than the sustained-release versions [12] - New drug developments are underway, including a potential first-in-class medication for ADHD currently in clinical trials [12]
Nature:这种困扰罗永浩的疾病,与三个罕见基因变异有关
生物世界· 2025-12-31 09:00
Core Viewpoint - The article discusses a significant study identifying rare genetic variants associated with Attention Deficit Hyperactivity Disorder (ADHD), revealing that individuals carrying these variants have a substantially higher risk of developing ADHD compared to the general population [4][9]. Group 1: ADHD Overview - ADHD is a neurodevelopmental disorder affecting approximately 5% of children globally, with about half of these cases persisting into adulthood, leading to various severe consequences [3]. - The study highlights the importance of understanding the biological mechanisms driving ADHD for future treatment and intervention strategies [3]. Group 2: Research Findings - A groundbreaking study published in Nature identified three rare genetic variants—MAP1A, ANO8, and ANK2—significantly linked to ADHD risk, with individuals carrying these variants having a 5.55 to 15.31 times higher risk of developing the disorder [4][9]. - The research involved a large sample size of 8,895 ADHD patients and 53,780 healthy controls, focusing on rare coding gene variants that can severely impact protein function [7]. Group 3: Genetic Mechanisms - MAP1A is crucial for microtubule assembly and neuronal structure, while ANO8 and ANK2 are involved in calcium ion transport, indicating that ion channel dysfunction plays a significant role in ADHD [11]. - The study found that these rare variants not only increase the risk of ADHD but also significantly affect cognitive function and socioeconomic status, with carriers being 24% more likely to complete only basic education and 28% more likely to experience low socioeconomic status [14]. Group 4: Combined Genetic Effects - The research explored the combined effects of common and rare genetic variants, revealing that they contribute to ADHD risk additively, with rare variants acting as risk accelerators [17]. Group 5: Implications for Future Research - The findings suggest that the identified genes explain only 5.2% of the heritability associated with rare variants, indicating that more ADHD risk genes remain to be discovered [19]. - Long-term implications include the potential for developing precise diagnostic methods, personalized treatment strategies, and reducing stigma associated with ADHD by clarifying its biological basis [20].
罗永浩自曝患ADHD多年,发布会未彩排硬讲
Xin Lang Cai Jing· 2025-12-31 02:24
特别声明:以上文章内容仅代表作者本人观点,不代表新浪网观点或立场。如有关于作品内容、版权或其它问 题请于作品发表后的30日内与新浪网联系。 罗永浩自曝患ADHD多年,发布会未彩排硬讲 罗永浩自曝患ADHD多年,发布会未彩排硬讲 #罗永浩自曝ADHD# 罗永浩迟到后自曝患病十几年:患ADHD,体力已不太行,发布会没彩排直接硬 讲。#罗永浩说遥遥领先成全国笑柄# ...
罗永浩之夜:道歉、退票、与豆包辩论
Shang Hai Zheng Quan Bao· 2025-12-31 00:50
Core Viewpoint - The event "The Crossroads of Luo Yonghao," known as the "Tech Spring Festival," faced delays and issues, leading to Luo Yonghao apologizing multiple times and offering full refunds for ticket purchases, ultimately making the event free for attendees [1][4][12]. Group 1: Event Details - The event took place on December 30 in Shanghai, marking Luo Yonghao's return to the tech stage after seven years, with tickets selling out within two hours of release [4][12]. - Approximately 5,000 attendees filled the venue, but the event started over 40 minutes late due to unforeseen circumstances [1][4]. - Luo Yonghao announced a refund of over 1.66 million yuan from ticket sales and pledged to donate the same amount to a charity fund in Hong Kong [4][12]. Group 2: Personal Challenges - Luo Yonghao revealed he has been suffering from ADHD for many years, which has affected his ability to manage events effectively [6][7]. - He mentioned that his current medication is not as effective, and he has faced challenges with physical stamina during the event [7][9]. Group 3: Product Showcase - The event focused on showcasing innovative products, with over ten domestic tech products presented, emphasizing the need for platforms to highlight truly innovative offerings [12][14]. - Featured products included DJI's Neo2, ergonomic chairs, exoskeleton robots, and AI assistants, showcasing advancements in various tech fields [12][14]. Group 4: Future Aspirations - Luo Yonghao expressed his commitment to continue supporting innovative products and aims to enhance the visibility of Chinese technology on a global scale [12][14]. - He introduced an AI book analysis app called "Qie Ting," designed to provide deep insights into literature using advanced technology [15].
X @The Economist
The Economist· 2025-12-17 08:20
At the moment, ADHD is considered something you either have or you don’t. This binary approach to diagnosis has two consequences https://t.co/flbJTOPvvO ...